SCHEMBL20866751

SCHEMBL20866751

N#Cc1ccc2nccc(C(=N)OC(=N)N[C@H]3N=C(c4ccccc4)c4ccccc4NC3=O)c2c1

nearest known ligand 0.55

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CCKBR P32239 18/20 0.55
▸ CCKAR P32238 12/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24612203 1.00 CCKBR (0.55) CCKBRCCKAR
SCHEMBL20867113 0.85 CCKBR (0.47) CCKBRCCKAR
SCHEMBL20867112 0.85 CCKBR (0.47) CCKBRCCKAR
SCHEMBL24611973 0.85 CCKBR (0.61) CCKBRCCKAR
SCHEMBL24612084 0.83 CCKBR (0.55) CCKBRCCKAR
SCHEMBL20866700 0.82 CCKBR (0.61) CCKBRCCKAR
SCHEMBL24612170 0.82 CCKBR (0.55) CCKBRCCKAR
SCHEMBL20867148 0.82 CCKBR (0.55) CCKBRCCKAR
SCHEMBL20867040 0.81 CCKBR (0.55) CCKBRCCKAR
SCHEMBL20866985 0.81 CCKBR (0.61) CCKBRCCKAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019067864-A1 COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-04-04 — — WO disclosed
Send feedback